Genetic Analysis AS (XSAT:GEAN)

Genetic Analysis AS Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	14.51	24.03	13.37	16.29	25.32	46.81
Cash & Short-Term Investments	14.51	24.03	13.37	16.29	25.32	46.81
Cash Growth	-41.87%	79.70%	-17.92%	-35.66%	-45.90%	93.48%
Accounts Receivable	0.83	1.91	3.2	1.9	2.61	1.05
Other Receivables	6.11	3.81	4.16	9.15	4.99	6.95
Receivables	6.93	5.72	7.35	11.04	7.6	8
Inventory	1.46	0.8	0.76	1.54	1.75	2.37
Prepaid Expenses	-	0.52	0.21	0.18	0.76	0.42
Other Current Assets	-	-	-0	-	-	-
Total Current Assets	22.9	31.07	21.7	29.06	35.44	57.6
Property, Plant & Equipment	3.22	3.99	5.02	6.19	8.14	1.59
Long-Term Investments	-	-0.05	-0.05	0.41	-	-
Other Intangible Assets	18.52	0.36	0.47	0.58	0.15	0.16
Long-Term Deferred Charges	-	17.08	15.24	17.25	20.7	24.15
Other Long-Term Assets	-	-	-	-	-	-0
Total Assets	44.64	52.45	42.38	53.49	64.42	83.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.85	2.56	4.68	5.59	4.62	2.41
Accrued Expenses	-	5.5	5.23	8.49	6.55	6.05
Current Portion of Long-Term Debt	-	0.44	0.4	0.4	0.4	0.4
Current Portion of Leases	-	1.74	1.53	1.57	1.38	1.1
Current Unearned Revenue	-	8.74	-	-	-	-
Other Current Liabilities	13.28	0	-	-	-0	-
Total Current Liabilities	16.13	18.97	11.84	16.05	12.95	9.97
Long-Term Debt	6.19	3.96	4.4	0.3	0.7	1.1
Long-Term Leases	1.61	2.44	3.64	5.15	6.64	0.33
Other Long-Term Liabilities	-0	-	-0	-0	0	-
Total Liabilities	23.93	25.37	19.88	21.49	20.28	11.4

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	41.45	41.45	29.63	22.92	14.95	14.95
Additional Paid-In Capital	12.49	11.81	7.63	5.95	29.19	57.14
Retained Earnings	-33.23	-26.18	-14.77	-	-	-
Comprehensive Income & Other	-	-	0	3.13	-	0
Shareholders' Equity	20.71	27.08	22.49	32	44.14	72.09
Total Liabilities & Equity	44.64	52.45	42.38	53.49	64.42	83.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.8	8.58	9.97	7.42	9.12	2.93
Net Cash (Debt)	6.71	15.45	3.4	8.87	16.2	43.88
Net Cash Growth	-61.67%	354.74%	-61.71%	-45.23%	-63.08%	105.71%
Net Cash Per Share	0.11	0.24	0.08	0.34	0.65	1.75
Filing Date Shares Outstanding	69.09	69.09	49.38	38.2	24.92	24.92
Total Common Shares Outstanding	69.09	69.09	49.38	38.2	24.92	24.92
Working Capital	6.77	12.11	9.86	13.01	22.49	47.63
Book Value Per Share	0.30	0.39	0.46	0.84	1.77	2.89
Tangible Book Value	2.2	26.72	22.03	31.42	43.99	71.93
Tangible Book Value Per Share	0.03	0.39	0.45	0.82	1.77	2.89
Machinery	-	3.79	3.79	3.33	3.21	3.25

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error